"Swallow my Urine Back" : Inhibition of Detrusor Overactivity by Swallowing Maneuver

Observational Study to Estimate the Dry Mouth in OAB Patients With Solifenacin

NCT01437670 ·Status: COMPLETED

Post-treatment Novmalized Urodynamiz Findings as the Golden Standard of Objective Cure for Female Overactive Bladder Patients Receiving Antimuscarinic Drug

NCT01627145 ·Status: UNKNOWN ·Phase: NA

A Study Measuring and Tracking Changes in Overactive Bladder (OAB) Medication

NCT01317810 ·Status: WITHDRAWN

Effect of Long Acting Anticholinergic on Nocturnal Incontinence After Radical Cystectomy and Orthotopic Neobladder

NCT02877901 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Examining the Effects of Intra-detrusor Botox at Time of HoLEP in Men With Overactive Bladder Symptoms

NCT05878951 ·Status: RECRUITING ·Phase: PHASE2/PHASE3

A Pilot Trial in a Sleep Laboratory Setting to Observe Night Time Bladder Function of Subjects With Overactive Bladder (OAB)

NCT01099345 ·Status: TERMINATED

Evaluating a Digital Intervention for Overactive Bladder

NCT05170100 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Efficacy of Tolterodine on Specific Symptoms in Adult Patients With Overactive Bladder.

NCT00645281 ·Status: COMPLETED ·Phase: PHASE4

A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)

NCT00454896 ·Status: COMPLETED ·Phase: PHASE3

Effect of Detrol LA on Overactive Bladder Symptoms, Sexual Quality of Life and Sexual Function in Women

NCT00143481 ·Status: COMPLETED ·Phase: PHASE4

Bladder Diary for Diagnosing Bladder Oversensitivity

NCT04981015 ·Status: COMPLETED

Validation of a Real-time Urodynamic Measure of Urinary Urgency

NCT00909428 ·Status: COMPLETED ·Phase: PHASE4

Study of Topically Administered Oxybutynin Gel in Patients With Urge Incontinence

NCT00909181 ·Status: COMPLETED ·Phase: PHASE3

Urodynamics and Clinical Factors That Are Associated With Bladder Over-sensitivity

NCT03486639 ·Status: UNKNOWN

Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder

NCT00780832 ·Status: TERMINATED ·Phase: NA

Study Evaluating the Safety, Tolerability, and Efficacy of Dexmecamylamine (TC-5214) for Treatment of Overactive Bladder

NCT01868516 ·Status: COMPLETED ·Phase: PHASE2

A Study to Assess the Long Term Effect, Safety and Metabolism of a Solifenacin Liquid Suspension in Participants 5 to 18 Years of Age With Neurogenic Detrusor Overactivity

NCT01565694 ·Status: COMPLETED ·Phase: PHASE3

URO-902 in Female Subjects With Overactive Bladder and Urge Urinary Incontinence

NCT04211831 ·Status: COMPLETED ·Phase: PHASE2

Effects of Antimuscarinic Drugs on Overactive Bladder (OAB) Symptoms After Insertion of Ureteral Stents

NCT01210859 ·Status: WITHDRAWN

A Therapeutic Exploratory Clinical Study of DA-8010 in Patients With Overactive Bladder

NCT03566134 ·Status: COMPLETED ·Phase: PHASE2

Age-specific Prevalence and Comparisons of UDS and Bladder Diary Between OAB-wet and -Dry Women

NCT03807024 ·Status: COMPLETED

Feasibility of "At-home" Titration of Solifenacin

NCT00759577 ·Status: TERMINATED ·Phase: PHASE4

AQUA: Anticholinergic Side Effects QUestionnAire

NCT04791111 ·Status: COMPLETED

Developing a Simple Test to Diagnose Overactive Bladder

NCT05572918 ·Status: UNKNOWN

A Two-week Open-label Pharmacodynamic and Pharmacokinetic Study of Multiple Doses of a Darifenacin Liquid Oral Suspension in Children (2 - 15 Years) With Neurogenic Detrusor Overactivity

NCT00712322 ·Status: TERMINATED ·Phase: PHASE2